LRRK2 and Parkinson disease: The pathogenic mutations of LRRK2 were observed to have hyperphosphorylated kinase activity and emerging reports suggest that these mutations impair the mitophagy pathway thereby contributing to PD pathogenesis (Singh and Ganley 2021).